Showing 2,676 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Clinical trials

Ethics of hepatitis C drug pitch questioned

Editor's pick
Boston Globe
25 September 2012
New & experimental hepatitis C treatment

Simeprevir (TMC435) and TMC647055 Interferon Free Combination Hepatitis C Trial Will Commence Shortly

Editor's pick
Medivir press release
21 September 2012
Pharmaceutical industry

Boehringer Ingelheim exits virology research as hep C drugs move down pipeline

Editor's pick
Pharma Times
20 September 2012
Hepatitis B

Switching to tenofovir suppresses hepatitis B in HIV/HBV co-infected people

News
20 September 2012
New & experimental hepatitis C treatment

Medgenics' Bulging Pipeline Of Blockbuster Indications Takes On Big Pharma's Harmful Drugs

Editor's pick
Seeking Alpha
19 September 2012
New & experimental hepatitis C treatment

Casualties of an R&D war? Hep C trial patients accuse Bristol-Myers

Editor's pick
Fierce Biotech
18 September 2012
New & experimental hepatitis C treatment

Sofosbuvir appears safe and effective for HIV/HCV co-infected people

News
13 September 2012
Hepatitis C symptoms & diagnosis

Bacterial translocation is associated with more severe liver fibrosis in HIV/hepatitis C-co-infected people

News
13 September 2012
Hepatitis C treatment

Ordeal of hepatitis C treatment worth it

Editor's pick
San Francisco Chronicle
12 September 2012
Hepatitis B

Hepatitis B vaccine is effective for up to 15 years

News
12 September 2012
Hepatitis C treatment

Challenges remain in reaching 100% cure rate in HCV

Editor's pick
Healio Infectious Disease News
11 September 2012
Hepatitis C transmission & prevention

Man sentenced to 30 years for infecting five people with Hepatitis C

Editor's pick
First Coast News
11 September 2012
Elimination of hepatitis C

Irish national strategy for hepatitis C to be published

Editor's pick
Irish Times
5 September 2012
Hepatitis C symptoms & diagnosis

Chronic hepatitis C virus infection increases risk of death from both liver disease and non-liver-related causes

News
5 September 2012
Hepatitis B

Viread labeling updates

Editor's pick
EATG
30 August 2012
New & experimental hepatitis C treatment

Achillion Deal Looming as Hepatitis Drugs Fail: Real M&A

Editor's pick
Business Week
30 August 2012
Hepatitis C transmission & prevention

Massive increase of hepatitis C incidence in HIV-positive gay men in Switzerland

News
30 August 2012
Hepatitis C transmission & prevention

Hep C overshadows HIV, report shows

Editor's pick
GayNewsNetwork.com, Australia
28 August 2012
Hepatitis C treatment

Pre-emptive Escitalopram Can Prevent Depression during Hepatitis C Treatment

Editor's pick
HIVandHepatitis.com
24 August 2012
New & experimental hepatitis C treatment

Bristol-Myers Squibb Discontinues Development of BMS-986094, an Investigational NS5B Nucleotide for the Treatment of Hepatitis C

Editor's pick
Bristol Myers Squibb press release
24 August 2012
New & experimental hepatitis C treatment

Australia: New drugs offer hope to hepatitis C sufferers

Editor's pick
Sydney Morning Herald
24 August 2012
Hepatitis C treatment

Copy of Interferon, High Blood Pressure May be Risk to Vision

Editor's pick
Kaiser Daily Global Health Policy Report
23 August 2012
Hepatitis C treatment

Interferon, High Blood Pressure May be Risk to Vision

Editor's pick
AIDSMeds
23 August 2012
Money

Infections among homeless could fuel wider epidemics: study

Editor's pick
Reuters
23 August 2012